Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.

Abstract

The safety and immunogenicity of investigational conjugates, composed of the O-specific polysaccharides of Shigella sonnei and Shigella flexneri type 2a covalently bound to Pseudomonas aeruginosa recombinant exoprotein A (rEPA), were evaluated in 192 Israeli soldiers. None had significant local reactions or fever. Fourteen days after injection, 90% of S… (More)

Topics

Cite this paper

@article{Cohen1996SafetyAI, title={Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.}, author={D. Cohen and S. Ashkenazi and M. Green and Yehuda Lerman and Raphael Slepon and Geoffroy Robin and Nicholas H Orr and Darrin Taylor and Jerold Sadoff and Charleen T Chu and Joseph Shiloach and Rachel Schneerson and J. B. Robbins}, journal={Infection and immunity}, year={1996}, volume={64 10}, pages={4074-7} }